In the context of NAFLD, leptin has potential dual activity in exerting an early protective anti-steatotic response as well as late pro-inflammatory and pro-fibrogenic effects [11]. This evidence concerns the gene LEP and metabolic dysfunction-associated steatotic liver disease.